Aug 16 |
MediWound and Vericel win FDA paediatric label expansion for NexoBrid
|
Aug 15 |
Vericel gets FDA approval for NexoBrid for pediatric burn patients
|
Aug 15 |
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
|
Aug 7 |
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
|
Aug 5 |
What Makes Vericel (VCEL) a New Strong Buy Stock
|
Aug 4 |
Vericel Corporation (NASDAQ:VCEL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
|
Aug 3 |
Vericel Second Quarter 2024 Earnings: EPS Misses Expectations
|
Aug 2 |
The Latest Analyst Ratings For Vericel
|
Aug 1 |
Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
|